Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Gastrointestinal 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 16Advanced Solid Tumors 6Advanced Solid Tumor 5Solid Tumors 4Solid Tumor 4Mesothelioma 3Unspecified Childhood Solid Tumor, Protocol Specific 1Resectable Colon Cancer 1Relapsed Solid Tumor 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Patients With Advanced or Metastatic Solid Tumors 1Mesothelioma, Malignant 1Malignant Solid Tumour 1MSI-H Colorectal Cancer 1Locally Advanced and Metastatic Solid Tumors 1HER2-positive 1DMMR Colorectal Cancer 1Childhood Central Nervous System Choriocarcinoma 1Advanced Solid Tumour 1Advanced Solid Tumor Cancer 1

Interventions

Vorinostat 2pembrolizumab 1nintedanib 1dactolisib 1avelumab 1Vinorelbine 1Sunitinib 1Oxaliplatin 1Levoleucovorin 1Leucovorin 1Hydroxychloroquine 1Folfox protocol 1Fluorouracil 1Dasatinib 1DOXO-EMCH 1Cetuximab 1Bevacizumab 1BN 80927 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Solid Tumour × Oxaliplatin × Other solid neoplasm × Clear all
NCT01611857 2016-11-23

Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach

SCRI Development Innovations, LLC

Phase 1/2 Completed
49 enrolled 12 charts
GastrointestinalOther solid neoplasm

Malignant Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡